New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aridis Pharmaceuticals, Inc.
ARDS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

4457

Biotechnology

Next Earning date - 28 Oct 2024

4457

Biotechnology

Next Earning date - 28 Oct 2024

0.00USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-34%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

100%

Quote Panel

Shape
Updated October 26, 2024
1W 0.00 % 1M -90.00 % 3M -90.00 % 1Y -99.88 %

Key Metrics

Shape
  • Market Cap

    4457


  • Shares Outstanding

    44.57M


  • Share in Float

    37.29M


  • Dividende

    0


  • Earning Date

    28 Oct 2024


  • Price Target

    0.0001


  • Average Volume

    1522


  • Beta

    1.099


  • Range

    1.0E-4-0.096


  • Industry

    Biotechnology


  • Website

    https://www.aridispharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

-0.00x

P/B Ratio

-0.1

Debt/Equity

60.1%

Net Margin

$-0.2

EPS

How ARDS compares to sector?

P/E Ratio

Relative Strength

Shape

ARDS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$76M

Shape899%

2025-Revenue

$1.47

Shape1733%

2025-EPS

$15M

Shape-899%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

NA
vs -0.59

Q1.22

arrow
arrow

N/A

-0.92
vs NA

Q2.22

arrow
arrow

N/A

-0.45
vs -0.55

Q3.22

arrow
arrow

N/A

-0.42
vs -1.94

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

N/A

-0.92
vs -0.92

Q2.23

arrow
arrow

+173%

0.33
vs -0.45

Q3.23

arrow
arrow

N/A

-0.02
vs -0.42

Q4.23

arrow
arrow

N/A

-0.02
vs NA

Q1.24

arrow
arrow

+271%

1.58
vs -0.92

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

NA

570K  vs NA

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

+785%

292K  vs 33K

Q3.22

arrow
arrow

-100%

NA  vs 98K

Q4.22

arrow
arrow

-100%

NA  vs 570K

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

+6628%

19.6M  vs 292K

Q3.23

arrow
arrow

NA

417K  vs NA

Q4.23

arrow
arrow

NA

300K  vs NA

Q1.24

arrow
arrow

NA

319.6K  vs NA

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

+72%

0.72
vs 5.05

Q1.22

arrow
arrow

+40%

0.4
vs 0.72

Q2.22

arrow
arrow

+29%

0.29
vs 0.4

Q3.22

arrow
arrow

+25%

0.25
vs 0.29

Q4.22

arrow
arrow

+22%

0.22
vs 0.25

Q1.23

arrow
arrow

+26%

0.26
vs 0.22

Q2.23

arrow
arrow

-81%

-0.81
vs 0.26

Q3.23

arrow
arrow

+0%

0
vs -0.81

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

20

20
vs 20

NA

Q2.22

arrow
arrow

19

19
vs 20

-5%

Q3.22

arrow
arrow

16

16
vs 19

-16%

Q4.22

arrow
arrow

16

16
vs 16

NA

Q1.23

arrow
arrow

20

20
vs 16

25%

Q2.23

arrow
arrow

18

18
vs 20

-10%

Q3.23

arrow
arrow

1

1
vs 18

-94%

Q4.23

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News

ARDS

globenewswire.com

17 hours ago